Orasure Technologies Inc
- Last sale
- Oct 23, 2026 · +8.68%
- Market cap
- $285.12M
- 69.04M shares
- Filings
- 1,015
Q3 2026−38.1% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−25.6% FY25 yoy
- $285.12M
- —
- 2.5×
- 0.9×
- -17.40%
- —
Twelve months to Sep 30, 2026 · derived
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $115,021,000 | reported | |
| FY 2024 | 2024-12-31 | $185,827,000 | reported | |
| FY 2023 | 2023-12-31 | $405,472,000 | reported | |
| FY 2022 | 2022-12-31 | $387,479,000 | reported | |
| FY 2021 | 2021-12-31 | $233,674,000 | reported | |
| FY 2020 | 2020-12-31 | $171,721,000 | reported | |
| FY 2019 | 2019-12-31 | $154,605,000 | reported | |
| FY 2018 | 2018-12-31 | $181,743,000 | reported | |
| FY 2017 | 2017-12-31 | $167,064,000 | reported | |
| FY 2016 | 2016-12-31 | $128,198,000 | reported | |
| FY 2015 | 2015-12-31 | $119,719,000 | reported | |
| FY 2014 | 2014-12-31 | $106,464,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | — | $15.04M | $15.04M | — | 69.13M sh | −7.6% | — |
| FY2024 | — | $0.00 | $0.00 | — | 74.80M sh | +1.4% | 0.0% |
| FY2023 | — | $0.00 | $0.00 | — | 73.80M sh | +0.8% | 0.0% |
| FY2022 | — | $2.25M | $2.25M | — | 73.24M sh | +1.3% | — |
| FY2021 | — | $2.11M | $2.11M | — | 72.30M sh | +0.5% | — |
Segments
LineFY2022ShareChange
Diagnostics$303.67M78%+237.3%
Molecular Solutions$83.81M22%−41.7%
Total$387.48M
Surgical & medical instruments & apparatus
Orasure Technologies Inc is the 47th largest of the 144 covered companies the SEC files under this code, by revenue. SIC 3841
CompanyRevenueGrowthNet marginMarket cap
STIMNeuronetics, Inc.$149.2M99.2%26.1%$166.7MINFUInfuSystem Holdings, Inc$143.4M6.4%4.6%$295.5MXTNTXtant Medical Holdings, Inc.$133.9M14.2%3.7%$39.3M
OSUROrasure Technologies Inc (this company)$115.0M38.1%59.8%$285.1M
ANIKAnika Therapeutics, Inc.$112.8M5.9%9.6%$187.3MBBNXBeta Bionics, Inc.$100.3M53.9%73.0%$897.6MNPCENeuroPace Inc$100.0M25.1%21.5%$425.9MKMTSKestra Medical Technologies, Ltd.$95.1M59.0%138.4%$1.7BLUNGPulmonx Corp$90.5M8.0%59.7%$130.9MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Orasure Technologies Inc · CIK 1116463 · Engraved from SEC EDGAR